| First Author | Jiang R | Year | 2024 |
| Journal | Sci Adv | Volume | 10 |
| Issue | 29 | Pages | eadp5239 |
| PubMed ID | 39028822 | Mgi Jnum | J:352137 |
| Mgi Id | MGI:7704675 | Doi | 10.1126/sciadv.adp5239 |
| Citation | Jiang R, et al. (2024) Beta2 adrenergic receptor-mediated abnormal myelopoiesis drives neuroinflammation in aged patients with traumatic brain injury. Sci Adv 10(29):eadp5239 |
| abstractText | Aged patients often suffer poorer neurological recovery than younger patients after traumatic brain injury (TBI), but the mechanisms underlying this difference remain unclear. Here, we demonstrate abnormal myelopoiesis characterized by increased neutrophil and classical monocyte output but impaired nonclassical patrolling monocyte population in aged patients with TBI as well as in an aged murine TBI model. Retrograde and anterograde nerve tracing indicated that increased adrenergic input through the central amygdaloid nucleus-bone marrow axis drives abnormal myelopoiesis after TBI in a beta2-adrenergic receptor-dependent manner, which is notably enhanced in aged mice after injury. Selective blockade of beta2-adrenergic receptors rebalances abnormal myelopoiesis and improves the outcomes of aged mice after TBI. We therefore demonstrate that increased beta2-adrenergic input-driven abnormal myelopoiesis exacerbates post-TBI neuroinflammation in the aged, representing a mechanism underlying the poorer recovery of aged patients and that blockade of beta2-adrenergic receptor is a potential approach to promote neurological recovery after TBI. |
